AMDL, Inc. is a vertically integrated specialty pharmaceutical company that sells original equipment manufacturer (OEM) products and test kits. These products may be used by hospital, clinical, research and forensic laboratories and doctor’s offices to obtain precise and rapid... more

Matritech is using its patented proteomics technology to develop diagnostics for the detection of a variety of cancers. The Company's first two products, the NMP22® Test Kit and NMP22® BladderChek® Test, have been approved for both the monitoring and diagnosis of bladder cancer. The NMP22... more

DIANON provides a full line of anatomic and molecular pathology testing services and the CarePath(TM) Health Information Service, which provides personalized, diagnosis-specific information to physicians and their patients at critical moments in the healthcare process. DIANON has more... more

DiagnoCure Inc. (DiagnoCure) is a biotechnology company commercializing cancer diagnostic tests and delivering lab services. The Company specializes in the development of cancer diagnostic assays incorporating molecular markers. As of October 31, 2007, DiagnoCure had three wholly owned... more

Epigenomics AG is a Germany-based company engaged in the molecular diagnostics sector. It divides its products into two areas: solutions for early diagnosis of cancer and products for special diagnosis of cancer. Epigenomics AG produces and develops tests that help in the diagnosis of the... more

Clarient, Inc. (Clarient) is a cancer diagnostic company providing cellular assessment and cancer characterization to three customer groups: community pathologists, academic researchers and university hospitals, and biopharmaceutical companies. Clarient is engaged in delivering critical... more

TriPath develops, manufactures, markets, and sells innovative solutions to improve the clinical management of cancer, including detection, diagnosis, staging, and treatment. TriPath was formed in September 1999 through the merger of AutoCyte, Inc. and NeoPath, Inc. and acquisition of... more

Perceptronix Medical Inc. is a privately owned, cancer diagnostics company based in Vancouver, Canada. The company was founded in 1999 to commercialize innovative cancer diagnosis technologies developed in partnership with the BC Cancer Agency, a renowned cancer research and treatment... more

Biomoda, Inc. is a developmental stage company engaged in the business of developing biopharmaceutical technology to diagnose and treat human diseases. The Company currently licenses two patents in the U.S. On November 10, 1992, the Company licensed a patent for the detection of cancers... more

OncoMethylome Sciences is a bio-tech company dedicated to developing tests for early cancer detection and personalized treatment decisions. Specifically, OncoMethylome Sciences develops DNA gene methylation tests to assist physicians (i) in detecting cancer at an early stage with a... more

Biomarker Technologies, LLC is the worldwide technology provider of the BT Testâ„¢, a blood test which uses a patented process to screen a blood sample for indications of breast cancer. In recent studies, the BT Test identified non-treated breast cancer in women with an accuracy of... more

Sysmex UK is the British business subsidiary of The Sysmex Corporation of Japan, manufacturers of advanced blood analysers.

Medic Group is a privately held medical devices company whose mission is to improve patient care and survival by detecting and monitoring cancer and other diseases at their earliest stages. The company is currently developing a point-of-care medical device that detects and monitors tumor... more

Oncose, Inc. is an emerging market leader in cancer detection, diagnosis and treatment using proprietary technology to detect structural changes in glycoproteins that occur during oncogenesis. Glycoproteins are protein molecules with sugars (glycans) attached that are often found on cell... more